Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE LAPALU : revenue, balance sheet and financial ratios

SELARL PHARMACIE LAPALU is a French company founded 4 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in TOULOUSE (31200), this company of category PME shows in 2025 a net income positive of 208 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE LAPALU (SIREN 912475563)
Indicator 2025 2024 2023
Revenue N/C N/C N/C
Net income 208 211 € 124 163 € 84 867 €
EBITDA N/C N/C N/C
Net margin N/C N/C N/C

Revenue and income statement

In 2025, SELARL PHARMACIE LAPALU generates positive net income of 208 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2023-2025: 85 k€ -> 208 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

208 211 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 616%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 12%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

615.755%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

12.184%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

60.4%

Solvency indicators evolution
SELARL PHARMACIE LAPALU

Sector positioning

Debt ratio
615.75 2025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Watch

In 2025, the debt ratio of SELARL PHARMACIE LAPALU (615.75) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
12.18% 2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Watch

In 2025, the financial autonomy of SELARL PHARMACIE LAPALU (12.2%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 188.92. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

188.921

Liquidity indicators evolution
SELARL PHARMACIE LAPALU

Sector positioning

Liquidity ratio
188.92 2025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Good +25 pts over 3 years

In 2025, the liquidity ratio of SELARL PHARMACIE LAPALU (188.92) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of SELARL PHARMACIE LAPALU in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SELARL PHARMACIE LAPALU is estimated at 3 307 456 € (range 2 244 455€ - 5 189 854€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
2244k€ 3307k€ 5189k€
3 307 456 € Range: 2 244 455€ - 5 189 854€
NAF 5 année 2025

Valuation method used

Net Income Multiple
208 211 € × 15.9x = 3 307 456 €
Range: 2 244 456€ - 5 189 855€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE LAPALU with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE LAPALU

What is the revenue of SELARL PHARMACIE LAPALU ?

The revenue of SELARL PHARMACIE LAPALU is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE LAPALU profitable?

Yes, SELARL PHARMACIE LAPALU generated a net profit of 208 k€ in 2025.

Where is the headquarters of SELARL PHARMACIE LAPALU ?

The headquarters of SELARL PHARMACIE LAPALU is located in TOULOUSE (31200), in the department Haute-Garonne.

Where to find the tax return of SELARL PHARMACIE LAPALU ?

The tax return of SELARL PHARMACIE LAPALU is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE LAPALU operate?

SELARL PHARMACIE LAPALU operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.